Industry News - Tag: FDA

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Regulatory in brief / CBD, Norway, COVID-19

23 December 2020

The US Food and Drug Administration (FDA) has issued a number of warning letters to cannabidiol (CBD) companies, the Norwegian Medicines Agency (NoMA) is expanding the list of general-sale medicines, and the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has issued an exceptional us...

Read the full story

Regulatory in brief | NSAIDs, codeine, CMDh

22 October 2020

The US Food and Drug Administration (FDA) has implemented labelling changes for non-steroidal anti-inflammatory drugs (NSAIDs), New Zealand has confirmed the date for reverse-switching all medicines containing codeine from non-prescription to prescription status, and Europe's Coordination Group for...

Read the full story